+61 2-8964 9600 info@lucidhealthcon.com
  • Twitter
  • Linkedin
  • Twitter
  • Linkedin
Lucid Health Consulting
  • HOME
  • ABOUT
  • SERVICES
    • Reimbursement Submissions – PBAC and MSAC
    • Economic Evaluations
    • Statistical Analyses
    • Regulatory Strategy, Submissions & Compliance
    • Commercial Strategy
  • TEAM
  • ARTICLES
  • PUBLICATIONS
  • VIDEOS
  • CONTACT
Select Page
Lucid Health Consulting enters strategic agreement with MAOSS – for Australian Market Access Data

Lucid Health Consulting enters strategic agreement with MAOSS – for Australian Market Access Data

by George Papadopoulos | Nov 4, 2020 | Lucid Health Consulting News

Lucid Health Consulting is pleased to announce a strategic partnership agreement with MAOSS effective from 1 October 2020.             MAOSS is a unique market access platform, providing a one stop shop for Australian reimbursement data needs. MAOSS has been...

Recent Posts

  • 7th Annual Drugs & Devices Australia Webinar – Reimbursement Update 2021
  • ISPOR VOS Research RoundUp | July – August 2021
  • ARCS Foundation Bootcamp – Medical Devices: 16-17 August and 23-25 August, 2021.

Recent Comments

  • admin on Should discount rates be selectively applied in health economic evaluations?
  • Tim Hortons Buffalo on Should discount rates be selectively applied in health economic evaluations?

Archives

  • October 2021
  • August 2021
  • June 2021
  • April 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • July 2020
  • Twitter
  • Linkedin
Created by Spindrift Marketing| © Lucid Health Consulting 2020